These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33189955)

  • 1. Design and engineering of tumor-targeted, dual-acting cytotoxic nanoparticles.
    Voltà-Durán E; Serna N; Sánchez-García L; Aviñó A; Sánchez JM; López-Laguna H; Cano-Garrido O; Casanova I; Mangues R; Eritja R; Vázquez E; Villaverde A; Unzueta U
    Acta Biomater; 2021 Jan; 119():312-322. PubMed ID: 33189955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing Protein-Antitumoral Drug Nanoconjugates as Bifunctional Antimicrobial Agents.
    Serna N; Carratalá JV; Parladé E; Sánchez-Chardi A; Aviñó A; Unzueta U; Mangues R; Eritja R; Ferrer-Miralles N; Vazquez E; Villaverde A
    ACS Appl Mater Interfaces; 2020 Dec; 12(52):57746-57756. PubMed ID: 33325705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs.
    Sánchez-García L; Serna N; Álamo P; Sala R; Céspedes MV; Roldan M; Sánchez-Chardi A; Unzueta U; Casanova I; Mangues R; Vázquez E; Villaverde A
    J Control Release; 2018 Mar; 274():81-92. PubMed ID: 29408658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-Prolonged Release of Tumor-Targeted Protein-MMAE Nanoconjugates from Implantable Hybrid Materials.
    Serna N; Falgàs A; García-León A; Unzueta U; Núñez Y; Sánchez-Chardi A; Martínez-Torró C; Mangues R; Vazquez E; Casanova I; Villaverde A
    Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective CXCR4
    Díaz R; Pallarès V; Cano-Garrido O; Serna N; Sánchez-García L; Falgàs A; Pesarrodona M; Unzueta U; Sánchez-Chardi A; Sánchez JM; Casanova I; Vázquez E; Mangues R; Villaverde A
    Small; 2018 Jun; 14(26):e1800665. PubMed ID: 29845742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination.
    Pallarès V; Unzueta U; Falgàs A; Sánchez-García L; Serna N; Gallardo A; Morris GA; Alba-Castellón L; Álamo P; Sierra J; Villaverde A; Vázquez E; Casanova I; Mangues R
    J Hematol Oncol; 2020 Apr; 13(1):36. PubMed ID: 32295630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering non-antibody human proteins as efficient scaffolds for selective, receptor-targeted drug delivery.
    Serna N; Pallarès V; Unzueta U; Garcia-Leon A; Voltà-Durán E; Sánchez-Chardi A; Parladé E; Rueda A; Casanova I; Falgàs A; Alba-Castellón L; Sierra J; Villaverde A; Vázquez E; Mangues R
    J Control Release; 2022 Mar; 343():277-287. PubMed ID: 35051493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-driven nanomedicines in oncotherapy.
    Casanova I; Unzueta U; Arroyo-Solera I; Céspedes MV; Villaverde A; Mangues R; Vazquez E
    Curr Opin Pharmacol; 2019 Aug; 47():1-7. PubMed ID: 30685732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A refined cocktailing of pro-apoptotic nanoparticles boosts anti-tumor activity.
    Sánchez-García L; Sala R; Serna N; Álamo P; Parladé E; Alba-Castellón L; Voltà-Durán E; Sánchez-Chardi A; Unzueta U; Vázquez E; Mangues R; Villaverde A
    Acta Biomater; 2020 Sep; 113():584-596. PubMed ID: 32603867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural and Designed Toxins for Precise Therapy: Modern Approaches in Experimental Oncology.
    Shilova O; Shramova E; Proshkina G; Deyev S
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered Polymer-Transferrin Conjugates as Self-Assembling Targeted Drug Delivery Systems.
    Makwana H; Mastrotto F; Magnusson JP; Sleep D; Hay J; Nicholls KJ; Allen S; Alexander C
    Biomacromolecules; 2017 May; 18(5):1532-1543. PubMed ID: 28350442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of cultured mammalian cells to the exotoxins of Pseudomonas aeruginosa and Corynebacterium diphtheriae: differential cytotoxicity.
    Middlebrook JL; Dorland RB
    Can J Microbiol; 1977 Feb; 23(2):183-9. PubMed ID: 65205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visible light-induced apoptosis activatable nanoparticles of photosensitizer-DEVD-anticancer drug conjugate for targeted cancer therapy.
    Um W; Park J; Ko H; Lim S; Yoon HY; Shim MK; Lee S; Ko YJ; Kim MJ; Park JH; Lim DK; Byun Y; Kwon IC; Kim K
    Biomaterials; 2019 Dec; 224():119494. PubMed ID: 31542518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactoferrin-dual drug nanoconjugate: Synergistic anti-tumor efficacy of docetaxel and the NF-κB inhibitor celastrol.
    Abdelmoneem MA; Abd Elwakil MM; Khattab SN; Helmy MW; Bekhit AA; Abdulkader MA; Zaky A; Teleb M; Elkhodairy KA; Albericio F; Elzoghby AO
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111422. PubMed ID: 33255023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruiting potent membrane penetrability in tumor cell-targeted protein-only nanoparticles.
    Serna N; Sánchez JM; Unzueta U; Sánchez-García L; Sánchez-Chardi A; Mangues R; Vázquez E; Villaverde A
    Nanotechnology; 2019 Mar; 30(11):115101. PubMed ID: 30561375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGD-Modified Albumin Nanoconjugates for Targeted Delivery of a Porphyrin Photosensitizer.
    Li F; Zhao Y; Mao C; Kong Y; Ming X
    Mol Pharm; 2017 Aug; 14(8):2793-2804. PubMed ID: 28700237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicines.
    Álamo P; Cedano J; Conchillo-Sole O; Cano-Garrido O; Alba-Castellon L; Serna N; Aviñó A; Carrasco-Diaz LM; Sánchez-Chardi A; Martinez-Torró C; Gallardo A; Cano M; Eritja R; Villaverde A; Mangues R; Vazquez E; Unzueta U
    Acta Biomater; 2021 Aug; 130():211-222. PubMed ID: 34116228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic RGD-Peptide-Functionalized Polylipopeptide Micelles for Enhanced Loading and Targeted Delivery of Monomethyl Auristatin E.
    Qiu M; Wang X; Sun H; Zhang J; Deng C; Zhong Z
    Mol Pharm; 2018 Nov; 15(11):4854-4861. PubMed ID: 30259747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.